332 related articles for article (PubMed ID: 10915747)
1. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.
Tanaka E; Ohue C; Aoyagi K; Yamaguchi K; Yagi S; Kiyosawa K; Alter HJ
Hepatology; 2000 Aug; 32(2):388-93. PubMed ID: 10915747
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
[TBL] [Abstract][Full Text] [Related]
3. Total HCV core antigen assay. A new marker of HCV viremia and its application during treatment of chronic hepatitis C.
Lorenzo J; Castro A; Aguilera A; Prieto E; López-Calvo S; Regueiro B; Pedreira J
J Virol Methods; 2004 Sep; 120(2):173-7. PubMed ID: 15288960
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients.
Medhi S; Potukuchi SK; Polipalli SK; Swargiary SS; Deka P; Chaudhary A; Begum N; Hussain Z; Ahlawat RS; Kar P
Clin Biochem; 2008 May; 41(7-8):447-52. PubMed ID: 18267117
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
Kawai S; Yokosuka O; Imazeki F; Saisho H; Mizuno C
J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820
[TBL] [Abstract][Full Text] [Related]
7. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY
Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
[TBL] [Abstract][Full Text] [Related]
8. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of clinical usefulness of second-generation HCV core antigen assay: comparison with COBAS AMPLICOR HCV MONITOR assay version 2.0.
Yokosuka O; Kawai S; Suzuki Y; Fukai K; Imazeki F; Kanda T; Tada M; Mikata R; Hata A; Saisho H
Liver Int; 2005 Dec; 25(6):1136-41. PubMed ID: 16343063
[TBL] [Abstract][Full Text] [Related]
10. Performance of two Real-Time RT-PCR assays for quantitation of hepatitis C virus RNA: evaluation on HCV genotypes 1-4.
Elkady A; Tanaka Y; Kurbanov F; Sugauchi F; Sugiyama M; Khan A; Ali EM; Mouhamed L; Abou el-fetouh S; AbdEl-Hameed AR; Mizokami M
J Med Virol; 2010 Nov; 82(11):1878-88. PubMed ID: 20872714
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation on the use of detection of hepatitis C core antigen for screening blood donor].
Wang FC; Shi ZY; Cai J; Su J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):389-90. PubMed ID: 18322613
[TBL] [Abstract][Full Text] [Related]
12. Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C: analysis by a prospective study.
Muto H; Tanaka E; Matsumoto A; Yoshizawa K; Kiyosawa K;
J Gastroenterol; 2004 Jul; 39(7):674-80. PubMed ID: 15293139
[TBL] [Abstract][Full Text] [Related]
13. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan.
Agha S; Tanaka Y; Saudy N; Kurbanov F; Abo-Zeid M; El-Malky M; Khalaf M; Ohta N; Yoshizawa H; Mizokami M
J Med Virol; 2004 Jun; 73(2):216-22. PubMed ID: 15122795
[TBL] [Abstract][Full Text] [Related]
14. [Clinical benefit of HCV core antigen assay in patients receiving interferon and ribavirin combination therapy].
Higashimoto M; Takahashi M; Jokyu R; Saito H
Rinsho Byori; 2006 Feb; 54(2):111-5. PubMed ID: 16548229
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.
Alzahrani AJ
J Med Virol; 2008 Apr; 80(4):603-6. PubMed ID: 18297713
[TBL] [Abstract][Full Text] [Related]
16. Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response.
Moreno M; Pérez-Alvarez R; Rodrigo L; Pérez-López R; Suárez-Leiva P
J Viral Hepat; 2006 Jan; 13(1):28-33. PubMed ID: 16364079
[TBL] [Abstract][Full Text] [Related]
17. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
18. Profiles of HCV core protein and viremia in chronic hepatitis C: possible protective role of core antigen in liver damage.
Carabaich A; Ruvoletto M; Bernardinello E; Tono N; Cavalletto L; Chemello L; Gatta A; Pontisso P
J Med Virol; 2005 May; 76(1):55-60. PubMed ID: 15778969
[TBL] [Abstract][Full Text] [Related]
19. Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction.
Negro F; Krawczynski K; Quadri R; Rubbia-Brandt L; Mondelli M; Zarski JP; Hadengue A
Hepatology; 1999 Feb; 29(2):536-42. PubMed ID: 9918932
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
